NCT06670417

Brief Summary

The goal of this clinical trial is to evaluate the effect of extravascular Low-level laser therapy (LLLT) versus offloading exercises on foot ulcers healing (DFUs) in type 2 diabetic patients. could include sixty patients with type 2 diabetes associated with diabetic foot ulcer as a complication, their ages ranging from 45 - 55 years. Patients will be selected from Faculty of Medicine (Kasr Al-Aini) Cairo University. They will be referred by the physician after a complete medical evaluation. . The main question it aims to answer is there any significant difference between extravascular low-level laser therapy and offloading exercise on diabetic foot ulcer healing in type 2 diabetic patients ? After clinical assessment patients will be randomly allocated into three groups equal in number: Group (A) (Experimental A): will receive extravascular low level laser therapy LLLT (laser watch device) combined with their prescribed hypoglycaemic medications(oral and insulin) and usual wound care for 12 weeks (3 sessions/ week). Group (B) (Experimental B): will receive Offloading exercise inform of burger allen exercise combined with their prescribed hypoglycaemic medications(oral and insulin) and usual wound care for 12 weeks (3 sessions/ week). Group (C) Control group will receive their prescribed hypoglycaemic medications(oral and insulin) and usual wound care only for 12 weeks (3 sessions/ week).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 1, 2024

Completed
29 days until next milestone

Study Start

First participant enrolled

November 30, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

November 5, 2024

Status Verified

December 1, 2023

Enrollment Period

1.1 years

First QC Date

October 31, 2024

Last Update Submit

November 4, 2024

Conditions

Keywords

Low level laserDiabetic Foot UlcerBlood glucose level

Outcome Measures

Primary Outcomes (2)

  • wound surface area

    From enrollment to the end of treatment at 2 weeks

  • Glycated hemoglobin HbA1c

    From enrollment to the end of treatment at 12weeks

Study Arms (3)

Group (A) (Experimental A): will receive extravascular low level laser therapy LLLT (laser watch dev

EXPERIMENTAL
Device: Low level laser therapy watch: The laser watch device was a semiconductor LLL therapeutic apparatus, (model:SL-03 GaALAs semiconductor) Domer Laser Therapy Watch class 3B 650nm low-level laser light

B) (Experimental B): will receive Offloading exercise inform of burger allen exercise combined with

EXPERIMENTAL
Other: Buerger Allen exercise

(C) Control group will receive their prescribed hypoglycaemic medications(oral and insulin) and usua

EXPERIMENTAL
Other: Regular wound care

Interventions

Low level laser therapy watch: The laser watch device was a semiconductor LLL therapeutic apparatus, (model:SL-03 GaALAs semiconductor) Domer Laser Therapy Watch class 3B 650nm low-level laser light. It provides 18 individual laser beams used for extravascular blood irradiation (transcutaneous) through radial and ulnar vessels at the wrist site.

Group (A) (Experimental A): will receive extravascular low level laser therapy LLLT (laser watch dev

Procedure-Keep the Buerger Allen exercise board on the cot. Elevate the lower extremities to an angle of 45 to 90 degree with the help of exercise board. Provided support to the lower extremities to maintain the position. Make the subject to maintain the same position in the same manner until the skin blanches (appears dead white). Lower the feet and the legs below the level of the rest of the body until redness appears (care should be taken that there is no pressure against the back of the knees). Place the legs flat on the bed for a few minutes. Ask the subjects to sit in a relaxed position while each foot is flexed and extended then inverted and everted for 3 minutes till the feet turns entirely pink. Ask the subject to rotate the feet in all the direction. Make the subject to lie quietly for 5 minutes, keeping legs warm with a blanket

B) (Experimental B): will receive Offloading exercise inform of burger allen exercise combined with

Regular wound care and dressing to the wound and ulcer

(C) Control group will receive their prescribed hypoglycaemic medications(oral and insulin) and usua

Eligibility Criteria

Age45 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Body mass index of 25-34.9 kg/m2.
  • Glycated hemoglobin (HbA1c) \>7 %.
  • ABP index absolute normal (1-1.3)
  • Patient with polyneuropathy.
  • Patient suffer from diabetes more than 5 years.
  • Patient has chronic unhealed diabetic ulcer from 4 weeks up to 6 weeks.

You may not qualify if:

  • Patients with history of hypo- hyperglycemic coma.
  • Uncontrolled cardiovascular complications.
  • Malignancy, Anemia, Hemorrhagic diseases.
  • Cardiac peace maker.
  • Deep venous thrombosis.
  • Osteomyelitis.
  • Patients with Monckeberg sclerosis.
  • Photosensitivity to laser.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy

Giza, Dokki, 11432, Egypt

Location

MeSH Terms

Conditions

Diabetic Foot

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Central Study Contacts

Hebatullah Emad lecturer Assistant

CONTACT

Hend Abdel Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer Assistant

Study Record Dates

First Submitted

October 31, 2024

First Posted

November 1, 2024

Study Start

November 30, 2024

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

November 5, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations